探访第八届进博会医疗馆：“中国创新”浓度飙升，健康生活科技感扑面而来

Group 1 - The China International Import Expo (CIIE) has become a significant platform for global companies to showcase innovations and deepen international cooperation, particularly in the healthcare sector [1] - The eighth CIIE opened on November 5, 2025, in Shanghai, featuring a record number of global product launches and highlighting China's strategic position in the global health industry [1] - Major international medical companies like Siemens Healthineers, GE Healthcare, and Pfizer showcased numerous innovative products, with a focus on "China R&D, global debut" [1][2] Group 2 - GE Healthcare presented nearly 40 innovative products, with 60% led by Chinese teams, marking a record high for the expo [2] - Medtronic's first heart pacing catheter developed in China exemplifies the "local innovation, global sharing" model, with significant local procurement and investments in startups [3] - Pfizer aims to accelerate the approval of 60 innovative drugs in China by 2030, having already achieved over half of this goal [3] Group 3 - AI has become an essential feature in medical products, with Siemens showcasing AI-driven innovations that enhance clinical decision-making and patient care [5][6] - Philips emphasized its commitment to local innovation, with over 95% of its products developed and manufactured in China [4] - The integration of AI in healthcare is expanding from hospitals to home care, with Philips investing significantly in AI and data science [7] Group 4 - The expo highlighted innovative drugs for rare diseases, with Sanofi launching two significant cardiovascular drugs [8] - Gilead Sciences introduced a long-acting HIV prevention drug, achieving a record for global synchronization in its launch [9] - The CIIE has become a vital platform for the rapid introduction of new therapies to benefit Chinese patients [9]